Longevity Health Holdings, Inc. (OTCPK: XAGE)
Health Care · Biotechnology · US
$0.22
-30.16% today · -90.9% 1Y
Longevity Health Holdings, Inc. (OTCPK: XAGE) operates in the Biotechnology industry within the Health Care sector. The company is valued at $549.77K and employs 10 people.
Over the last twelve months the share price has lost 90.9%, trading between 0.21 and 2.85.
Tweenvest scores Longevity Health Holdings, Inc. across four factors: quality 16/100, value 50/100. Its strongest factor is value.
XAGE price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $549.77K
- Revenue (TTM)
- $1.69M
- P/E
- —
- EPS
- -3.46
- Dividend yield
- —
- Beta (5Y)
- 0.40
- 52-week high
- $2.85
- 52-week low
- $0.21
- Avg volume (3M)
- —
- Shares outstanding
- 2.48M
- Employees
- 10
- Next earnings
- —
About Longevity Health Holdings, Inc.
Longevity Health Holdings Inc. specializes in creating plasma-based bioactive materials (PBMs) aimed at fostering tissue regeneration and repair in response to injury, illness, and the natural aging process. The company's primary investigational product is CT-101, which acts as a powerful accelerant for bone healing in diverse applications such as tibia fracture recovery, foot/ankle and spinal fusions, serving as a dental bone graft substitute, and filling bone voids. Additionally, CT-101 functions as a tissue healing accelerant, offering potential for treating androgenetic alopecia and persistent chronic wounds. Established in 2008, the company maintains its headquarters in Pittsburgh, Pennsylvania.
- Founded
- 2008
- Listed since
- Sep 23, 2021
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $468.22B | $266.31 | +0.51% |
| Amgen Inc.NasdaqGS: AMGN | $237.52B | $441.75 | +0.55% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $181.18B | $146.61 | +0.34% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $138.91B | $548.05 | +1.44% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $83.28B | $834.04 | +0.90% |
| argenx SEENXTBR: ARGX | $65.85B | €883.80 | -2.02% |
| Moderna, Inc.NasdaqGS: MRNA | $57.92B | $143.00 | -1.43% |
| CSL LimitedASX: CSL | $57.77B | AU$168.30 | -1.69% |
Figures last refreshed Aug 18, 2026.